Size, shape, porosity and surface chemistry are all important, and the ability to control them in SBA-15 is crucial for successful biocompatible design using this platform.
Using this approach, we synthesized a biocompatible and biodegradable copolymer with T g of 5.6°C from monomers of L-lactide, poly ethylene glycol) (PEG), and NIPAAm [ 16].
This result suggested the possibility for biocompatible design of hydrophobic group RTILs to achieve biological applications with living cells.
Their specific properties can be used in designing biocompatible nanocarriers or smart cargoes for biomedical applications.
In this direction, we designed an amperometric biosensor using a biocompatible conjugate to diagnose cancer metastasis by detecting epithelial cell adhesion molecule expressing metastatic cancer cells (Ep-MCCs).
have been used for the design of biocompatible scaffolds, but they are still less efficient than natural biopolymers such as collagen extracts.
The approach outlined in this work is potentially generalizable as a new platform, using only biocompatible materials in situ, to treat nanoparticles before they are inhaled.
In 2007, our group designed, using biocompatible material, an organomorphic scaffold bioreactor unit for bioengineering ex situ the human thyroid gland, chosen as a model for its simple anatomical organization (repetitive follicular cavities).
However, the surface modification of this nanostructure using biocompatible polymers or inorganic components remains a challenge [10 18].
This represents a general de novo design approach by using biocompatible fragments, thus preventing the use of synthetic fragments with debatable biological properties.
